Global cell and gene therapy supply chain strategies at commercial scale 2020

Best practice for raw materials management on a global basis

Cell & Gene Therapy Insights 2020; 6(2), 339–345


Published: 24 April 2020
Stephane Lameynardie

Stephane Lameynardie has a Pharm D from the University of Montpellier with specialization in Industrial and Biomedical Pharmaceutical Sciences. He has worked in the industry for the last 20 years in various domains ranging from QA and GMP manufacturing to Project Management and Development, and across both small and large organizations.